Mondaq Asia Pacific: Food, Drugs, Healthcare, Life Sciences > Life Sciences, Biotechnology & Nanotechnology
DeHeng Law Offices
近几个月来医疗器械行业内改革动作频频。医疗器械注册人制度试点扩大到21个省,有如释放行业创新活力的一剂良方,监管方通过将产研分开&#
Ropes & Gray LLP
After continuously reshaping the competitive landscape in the pharmaceutical industry for several years, the Chinese government finally shifted its attention to the medtech industry.
Hogan Lovells
On 28 May 2019, the People's Republic of China State Council promulgated the People's Republic of China Human Genetic Resources
Spruson & Ferguson
Anyone who collects, preserves, utilizes or provides China's human genetic resources should comply with the regulations.
Ropes & Gray LLP
China's State Council, the country's top administrative authority, released a new Regulation of Human Genetic Resources1 (the "Regulation") on May 28, 2019, to replace the tentative rules issued
Hogan Lovells
T he past year is set to be a milestone year for China's pharmaceutical regulatory reform as the newly formed National Medical Products Administration (NMPA) continues to aggressively cut back on red
Mayer Brown
On 30 December 2018, China's State Administration for Market Regulation (SAMR) issued an infringement decision imposing a total fine of CNY 10.04 million
Ropes & Gray LLP
China's drug and device regulator recently announced a set of rules signaling increased scrutiny of foreign drug and device companies.
Singh & Associates
These cells are central to many blood cancers, including common forms of lymphoma and leukaemia.
Singh & Associates
On February 28, 2019, European Medicine Agency published the first guidance on new rules for certain medical devices - the first of a series of guidance documents to help applicants to prepare for compliance with these new rules.
Skadden, Arps, Slate, Meagher & Flom (UK) LLP
In the past year, nearly a dozen companies have taken advantage of new rules to list on the Stock Exchange of Hong Kong Limited (HKEx).
LexOrbis
When Hitachi design a nose cone for the Japanese bullet train using AI which improved aerodynamic performance and reduced cabin noise levels
Nishith Desai Associates
This is one scuffle which has rocked the two crown establishments in pharma space and has taken them through a roller coaster ride. The battalion
LexOrbis
Substances used for in vitro diagnosis, medical device, mechanical contraceptives, disinfectants and insecticides and other notified devices in India are now regulated by the Medical Device Rules, 2017...
LexOrbis
India released the draft regulatory guidelines for ‘Similar Biologics' at the BIO industry conference in Boston, USA, on 19 June 2012.
LexOrbis
Patents in India are allowed in all fields of technology, even though the factors determining patentability of an invention varies for dierent technologies.
Khurana and Khurana
Monsanto Company is an agrochemical and agricultural biotechnology corporation acquired by Bayer Corporation that conducts research on genetically modified seeds and agricultural crops.
Nishith Desai Associates
SBI (through its investment vehicles in Japan and Singapore), Beenext, along with other investors led the Series B investment of approx. USD 17 million
Singh & Associates
On April 23, 2019, Indian Council of Medical Research (ICMR) licensed the technology for Shigella vaccine for further scaling up and commercialisation to MSD Wellcome Trust Hilleman Laboratories Pvt Ltd.
Nishith Desai Associates
January 01, 2019 marked the first anniversary of the Medical Device Rules 2017 – India's first step in de-linking medical devices regulations from drugs.
Latest Video
Most Popular Recent Articles
Khurana and Khurana
Monsanto Company is an agrochemical and agricultural biotechnology corporation acquired by Bayer Corporation that conducts research on genetically modified seeds and agricultural crops.
Singh & Associates
The National Pharmaceutical Pricing Authority, is an executive body under the Drugs (Prices Control) Order, 2013, under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India.
Khurana and Khurana
They are also open to patent term adjustments and corrections too.
Nishith Desai Associates
This is one scuffle which has rocked the two crown establishments in pharma space and has taken them through a roller coaster ride. The battalion
Khurana and Khurana
It cannot be debated that E-pharmacy cannot be equated with normal e-commerce platform.
Hogan Lovells
On 28 May 2019, the People's Republic of China State Council promulgated the People's Republic of China Human Genetic Resources
Saint Island International Patent & Law Offices
The PIF system employed in the new law was modeled after the EU counterpart.
Singh & Associates
Biotechnology inventions are important for human development. It is the broad area of biology involving living systems and organisms to develop or make products, or any technological application ...
Khurana and Khurana
A decade ago, the whole country was sent flying into a state of bewilderment by the news headlines flashing on the TV screens that morning.
Duncan Cotterill
The Biosecurity Act is to be reviewed partly as a result of flaws highlighted because of the Mycoplasma bovis outbreak.
Article Search Using Filters
Related Topics
Mondaq Advice Centre (MACs)
Popular Authors
Popular Contributors
Up-coming Events Search
Tools
Font Size:
Translation
Channels
Mondaq on Twitter